APA (7th ed.) Citation

I, K., N, Y., C, A., HS, T., S, S., S, T., . . . SF, T. (2021). Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels. Science advances, 7(41), eabi7511. https://doi.org/10.1126/sciadv.abi7511

Chicago Style (17th ed.) Citation

I, Kurth, et al. "Therapeutic Targeting of SLC6A8 Creatine Transporter Suppresses Colon Cancer Progression and Modulates Human Creatine Levels." Science Advances 7, no. 41 (2021): eabi7511. https://doi.org/10.1126/sciadv.abi7511.

MLA (9th ed.) Citation

I, Kurth, et al. "Therapeutic Targeting of SLC6A8 Creatine Transporter Suppresses Colon Cancer Progression and Modulates Human Creatine Levels." Science Advances, vol. 7, no. 41, 2021, p. eabi7511, https://doi.org/10.1126/sciadv.abi7511.